Niacin after coronary bypass grafting and for coronary disease prevention.
Parsons
W B
WB
D008076:Cholesterol, HDL / Q000097:blood / Q000187:drug effects; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects; D018849:Controlled Clinical Trials as Topic; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000097:blood / Q000517:prevention & control*; D023381:Endpoint Determination; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D017270:Lipoprotein(a) / Q000097:blood / Q000187:drug effects; D008297:Male; D009525:Niacin / Q000627:therapeutic use*; D010316:Particle Size; D012306:Risk; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D017270:Lipoprotein(a); D014280:Triglycerides; D009525:Niacin